Antibodies are indispensible research tools, yet the scientific community has not adopted standardized procedures to validate their specificity. Here we present a strategy to systematically validate antibodies for immunofluorescence (IF) applications using gene tagging. We have assessed the on- and off-target binding capabilities of 197 antibodies using 108 cell lines expressing EGFP-tagged target proteins at endogenous levels. Furthermore, we assessed batch-to-batch effects for 35 target proteins, showing that both the on- and off-target binding patterns vary significantly between antibody batches and that the proposed strategy serves as a reliable procedure for ensuring reproducibility upon production of new antibody batches. In summary,...
<div><p>We developed and optimized a high-throughput project workflow to generate renewable recombin...
Antibodies are among the most frequently used tools in research and have had a profound impact on th...
Because of our access to human genome data and ever improving genome sequencing and proteome analysi...
Antibodies are indispensible research tools, yet the scientific community has not adopted standardiz...
Antibodies are indispensible research tools, yet the scientific community has not adopted standardiz...
There is a need for standardized validation methods for antibody specificity and selectivity. Recent...
Antibodies are critical reagents to detect and characterize proteins. It is commonly understood that...
The field of proteomics has rapidly expanded due to the completion of the human genome sequence. Thi...
In situ protein detection in human tissues using antibodies reveals the cellular protein localizatio...
Validation of antibodies and other protein binders is a subject of pressing concern for the research...
Despite the wealth of commercially available antibodies to human proteins, research is often hindere...
Antibodies are widely exploited as research/diagnostic tools and therapeutics. Despite providing exc...
We developed and optimized a high-throughput project workflow to generate renewable recombinant anti...
Antibodies show potential to be used in a variety of applications, but they are difficult to work wi...
In the wake of the reproducibility crisis and numerous discussions on how commercially available ant...
<div><p>We developed and optimized a high-throughput project workflow to generate renewable recombin...
Antibodies are among the most frequently used tools in research and have had a profound impact on th...
Because of our access to human genome data and ever improving genome sequencing and proteome analysi...
Antibodies are indispensible research tools, yet the scientific community has not adopted standardiz...
Antibodies are indispensible research tools, yet the scientific community has not adopted standardiz...
There is a need for standardized validation methods for antibody specificity and selectivity. Recent...
Antibodies are critical reagents to detect and characterize proteins. It is commonly understood that...
The field of proteomics has rapidly expanded due to the completion of the human genome sequence. Thi...
In situ protein detection in human tissues using antibodies reveals the cellular protein localizatio...
Validation of antibodies and other protein binders is a subject of pressing concern for the research...
Despite the wealth of commercially available antibodies to human proteins, research is often hindere...
Antibodies are widely exploited as research/diagnostic tools and therapeutics. Despite providing exc...
We developed and optimized a high-throughput project workflow to generate renewable recombinant anti...
Antibodies show potential to be used in a variety of applications, but they are difficult to work wi...
In the wake of the reproducibility crisis and numerous discussions on how commercially available ant...
<div><p>We developed and optimized a high-throughput project workflow to generate renewable recombin...
Antibodies are among the most frequently used tools in research and have had a profound impact on th...
Because of our access to human genome data and ever improving genome sequencing and proteome analysi...